Multicenter, Open, Prospective, Randomized Trial of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Hypercholesterolemia
- Sponsor
- National Medical Research Center for Rehabilitation and Balneology
- Enrollment
- 80
- Locations
- 2
- Primary Endpoint
- Dynamics summary for improvement of aging biomarkers' values assessed by a patient's biochemical blood count
- Last Updated
- 4 years ago
Overview
Brief Summary
Reaching active aging makes it important to implement new methods affecting the biological age of a person. Biochemical parameters of a blood test are aging biomarkers that are ones of the most accessible for testing. We know that, with age, there is increase in levels of LDL, triglycerides, homocysteine and other biomarkers relating the body state.
Methods of extracorporeal hemocorrection showed good results in this area. For instance, the use of plasmapheresis is very effective during prophylaxis, treatment and rehabilitation after various diseases/injuries. The main effects of plasmapheresis are related to removal of endo- and exotoxins, including products of lipid peroxidation, and to draining effect as a result of a heavy flow of interstitial fluid containing products of pathometabolism into the blood stream within concentration gradient (by "dynamic equilibrium" in concentration of different substances in intracellular, interstitial and intravascular compartments). These effects are also related to release of receptors, their sensitization to their own neurohumoral regulation mechanisms, to insulin, in particular (as consequences, lower glucose tolerance, lower substrate glycation).
Detailed Description
Reaching active aging makes it important to implement new methods affecting the biological age of a person. Biochemical parameters of a blood test are aging biomarkers that are ones of the most accessible for testing. We know that, with age, there is increase in levels of LDL, triglycerides, homocysteine and other biomarkers relating the body state. One of the initial approaches of anti-ageing therapy is detoxification, reocorrection and immunocorrection. Methods of extracorporeal hemocorrection showed good results in this area. For instance, the use of plasmapheresis is very effective during prophylaxis, treatment and rehabilitation after various diseases/injuries. The main effects of plasmapheresis are related to removal of endo- and exotoxins, including products of lipid peroxidation, and to draining effect as a result of a heavy flow of interstitial fluid containing products of pathometabolism into the blood stream within concentration gradient (by "dynamic equilibrium" in concentration of different substances in intracellular, interstitial and intravascular compartments). These effects are also related to release of receptors, their sensitization to their own neurohumoral regulation mechanisms, to insulin, in particular (as consequences, lower glucose tolerance, lower substrate glycation). Thus, at this stage, experts assess effectiveness and organize data of existing prevention methods for premature aging and correction of aging biomarkers, as well as develop comprehensive programs for drug-free and pharmacological intervention. Introduction of the body detoxification method based on extracorporeal hemocorrection (developed in FGBU Russian Scientific Center for Medical Rehabilitation and Balneology of Ministry of Health of Russian Federation) may extend the range of effective and safe methods within such programs, as well as lower patients' biological age and, thus, lower risks of developing age-related diseases, decrease number of disability cases, which can contribute to life prolonging and improvement of its quality.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Signed informed consent form.
- •Men and women aged 40-
- •Body mass index \<30 kg / m
- •Level increase of one or several aging markers.
- •Understanding of requirements for study participants, written consent to participate in the study (including volunteer's consent for his/her health information related to the study to be used and passed on) and to perform procedures outlined in study protocol.
- •Negative pregnancy test for women of childbearing potential.
- •Non-inclusion Criteria:
- •Refusal to participate in the study.
- •Any health conditions that, according to investigators, might prevent volunteers from participating in the study.
- •Mental disorders, past medical history included.
Exclusion Criteria
- •Voluntary refusal to participate in the study.
- •Investigator doctor's decision on participant's exclusion for this participant's own benefit.
- •Participant refuses to cooperate with investigator or is undisciplined.
- •In case participant misses one or several study procedures or follow-up visits.
- •Development of severe adverse reactions or severe diseases/conditions unrelated to the study, requiring withdrawal from therapy.
- •Positive pregnancy test.
Outcomes
Primary Outcomes
Dynamics summary for improvement of aging biomarkers' values assessed by a patient's biochemical blood count
Time Frame: 1 month
Dynamics summary for improvement of aging biomarkers' values assessed by a patient's biochemical blood count at visit 6, compared with initial values (visit 0).
Secondary Outcomes
- Dynamics of results according to the method of "phenotypic age"(1 month)
- Dynamics of results according to the method of biological age(1 month)
- Dynamic pattern according to ECG results(1 month)
- Dynamics summary for aging biomarkers' values assessed by a patient's complete blood count(1 month)
- Dynamics summary for aging biomarkers' values assessed by a patient's blood serological test(1 month)
- Dynamic pattern according to results of vascular ultrasonography(1 month)
- scales of the "Health-Promoting Lifestyle Profile"(1 month)
- SF-36 scale(1 month)
- HAM questionnaire(1 month)
- Dynamics summary for improvement of aging biomarkers' values assessed by a patient's biochemical blood count(17 (+/- 2) days)
- Dynamics summary for aging biomarkers' values assessed by a patient's coagulation test(1 month)